A ray of hope has been found to cure people from malaria, as the initial results of the malaria vaccine, RTS, S have proven beneficial, and more than half of the malaria affected children, who received the vaccine, were found to be protected against the virus.

It has taken 25 long years to develop the vaccine, and has been made by GlaxoSmithKline. Seeing its fruitful results, the vaccine has been extended for children as well; earlier it was meant for the American military. The noble project was funded by the Bill and Melinda Gates Foundation.

Initial test reports would be presented at the Seattle malaria conference to be held on Tuesday, and one of the major announcements, which would be publicized in the conference is that if children of 5 to 17 months, who are suffering from acute malaria, take three doses of this vaccine, they would be benefitted, and the same has been proven as well, and the success ratio was 47%, taken out from 6,000 children.

Another revelation that would become part of the conference is that the clinical trials would be continued till 2014, and till now, over 15,000 children have received the vaccine. Lead researcher of the project, Dr. Tsiri Agbenyega from a Ghanaian hospital was of the view that initial success ratio has given them boost to move further, and they would try their best to have increasing success ratio. He further affirmed that the task needs to be speeded up as malaria is one of the diseases, which is proving to be quite taxing for children, as more than 780,000 Africans have lost their lives due to malaria. So, it is very important to save African children at the moment, especially when the World Health Organization has raised concern over malaria.